官方服务：
资源简介：
RNAseq of tumor samples from CT26 syngeneic mouse treated with a PI3Ka/d inhibitor (AZD8835)
应用场景：
创建时间：
2019-01-16
相关数据集
Gene expression profiles of myeloma cells treated with NAE inhibitor
The transcriptional profile of the human multiple myeloma (MM) cell line MM.1S treated with MLN4924 vs control MM.1S cells was characterized by oligonucleotide microarray analysis, using the human U13
NIAID Data Ecosystem90
Celecoxib induced transcriptional alterations in gastric cancer cells
Celecoxib is recognized to have chemopreventive and anti-cancer property beyond its anti-inflammatory function. Celelcoxib treatment in AGS cells down regulates Wnt/β-catenin, STAT3, RXR and ERK/MAPK
NIAID Data Ecosystem60
b457f181-f127-4ff8-a66c-f3d19246b706 - samples
RNAseq FASTq files from RT4 cells treated with KDM5i C70EGA dataset EGAD00001008000
NIAID Data Ecosystem40
Transcriptional pathway signatures for the Aurora inhibitor Danusertib. Homo sapiens
Treatment with Aurora inhibitors has been shown to induce diverse biological responses in different tumor cell lines, in part depending on their p53 status. To characterize at the transcriptional leve
NIAID Data Ecosystem60
Gene expression signature of T-ALL cell lines treated with the PI3K inhibitor AS605240
The PI3K pathway is frequently hyperactivated in primary T-cell acute lymphoblastic leukemia (T-ALL) cells. Activation of the PI3K pathway has been suggested as one mechanism of glucocorticoid resista
NIAID Data Ecosystem50
